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Purpose: Advanced glycation end products (AGE) are associated in the development of several pathophysiologies
including diabetic cataract. Earlier we have reported that some common dietary agents have antiglycating activity and
ginger (Zingiber officinalis) was one of the few prominent agents that effectively prevented AGE formation in vitro. In
this study we investigated the potential of ginger to prevent diabetic cataract in rats.
Methods: Diabetes was induced in Wistar-NIN rats by intraperitoneal injection of streptozotocin (35 mg/kg bodyweight)
and the control rats received vehicle alone. While a set of diabetic animals received AIN-93 diet, another set received
either 0.5 or 3% ginger in their diet for a period of two months. Cataract progression was monitored by slit-lamp
biomicroscope. At the end of two months, the animals were sacrificed to evaluate non-enzymatic glycation and osmotic
stress in the eye lens.
Results: Slit-lamp examination revealed that feeding of ginger not only delayed the onset but also the progression of
cataract in rats. Molecular analyses indicated that feeding of ginger significantly inhibited the formation of various AGE
products including carboxymethyl lysine in the eye lens. In addition, ginger also countered hyperglycemia-induced
osmotic stress in the lens.
Conclusions: The results indicated that ginger was effective against the development of diabetic cataract in rats mainly
through its antiglycating potential and to a lesser extent by inhibition of the polyol pathway. Thus, ingredients of dietary
sources, such as ginger, may be explored for the prevention or delay of diabetic complications.
The statistical facts indicate that the world, particularly
South-East Asia including India, is facing a growing diabetes
epidemic  of  potentially  devastating  proportions  [1,2].
Prolonged exposure to chronic hyperglycemia, without proper
management, can lead to various short-term and long-term
secondary complications, which represent the main cause of
morbidity  and  mortality  in  diabetic  patients.  Cataract,
characterized  by  the  opacification  of  the  eye  lens  that
interferes with transmission of light onto the retina, is one of
the earliest secondary complications of diabetes. Cataract is
the leading cause of visual impairment across the world and
studies indicate that the incidence of cataract is much higher
in diabetic than in non-diaetic individuals [3,4].
Considerable  evidence  suggests  that  the  long-term
pathological sequel of diabetes is a result of the accumulation
of  tissue  macromolecules  that  have  been  progressively
modified by non-enzymatic glycation [5-7]. Glycation is a
non-enzymatic  reaction  between  reducing  sugar  and  free
amino group of the protein (predominantly the ε-amino group
of lysine and the guanidine group of arginine) forming an
Amadori product [5-7]. The latter then undergoes a series of
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complex reactions (oxidative and nonoxidative) resulting in
the formation of advanced glycation end products (AGE).
Non-enzymatic glycation of lens protein has been considered
to be one of the major factors responsible for diabetic cataract
[7-10],  which  alters  protein  conformation  and  stability,
induces protein aggregation and cross-linking, and leads to
protein  insolubilization  [11-14].  Studies  also  show  the
formation of AGE not only plays a key role in the development
of diabetic cataract but also in the several pathophysiologies
associated  with  aging  and  diabetes  such  as  arthritis,
atherosclerosis,  chronic  renal  insufficiency,  Alzheimer
disease, nephropathy, and neuropathy [5,15-17]. This raises
the possibility that inhibition of AGE formation may prevent
the progression of diabetic complications including diabetic
cataract.
Aminoguanidine, a nucleophilic hydrazine compound,
has been extensively studied for its AGE inhibition [5,18,
19]. However, the trial was terminated due to various safety
concerns [5,18]. In case of cataract, aminoguanidine could
delay  the  progression  of  opacification  of  lens  only  in
moderately diabetic rats [20]. A wide variety of agents such
as pyridoxamine, carnosine, carnitine, lipoic acid, taurine,
OPB-9195,  and  phenyl  thiazolium  bromide  have  been
investigated in several in vitro and in vivo studies [5,21-23]
and some of these agents have been tested against cataract in
animal model. However, except pyridoxamine, none have
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1525progressed, as yet, to the stage of clinical trials. Thus, there is
a need for developing new antiglycating agents combining
higher levels of efficacy, selectivity and safety in humans.
In the context of a need for developing and testing new
antiglycating agents, we have evaluated several traditional
medicines and some common dietary agents and found that
some  spice  principles  have  the  potential  to  inhibit  AGE
formation under in vitro conditions [23] and in animal models
[24].  Among  them  ginger  was  one  of  the  agents  that
significantly  prevented  AGE  formation  in  vitro  [23].
Although, ginger (Zingiber officinale) is one of the commonly
used spices for culinary purposes, it has been used to treat a
variety of conditions such as arthritis, rheumatism, sprains,
muscular  aches,  pains,  sore  throats,  constipation,  and
indigestion in the traditional medicinal system of Asia [25].
Although, the hypoglycemic activity of ginger was found in
some studies [26,27], variable results have been reported in
different  studies  [28,29].  Since  we  found  obvious
antiglycating activity with aqueous extract of ginger in vitro
[23],  we  investigated  the  significance  of  its  antiglycating
potential under in vivo conditions using streptozotocin (STZ)-
induced diabetic cataract model in rats.
METHODS
Materials:  Streptozotocin  (STZ),  NADPH,  NADH,  2-
thiobarbituric acid (TBA), 1,1.3,3-tetraethoxy propane (TEP),
DL-glyceraldehyde  lithium  sulfate,  β-mercaptoethanol,
glutathione,  2,4-dinitrophenylhydrazine  (DNPH),  EDTA,
BSA,  methylglyoxal  (MGO),  Freund’s  complete  and
incomplete adjuvant, m-aminophenyl boronic acid, and HRP-
conjugated  goat  anti-rabbit  antibody  were  obtained  from
Sigma-Aldrich (St. Louis, MO). Glyoxylic acid and sodium
cyanoborohydride were purchased from ICN (Orangeburg,
NY).  Immobilon-NC  membrane  was  from  Millipore
(Bedford, MA) and protein A-sepharose beads were obtained
from  Amersham  Biosciences  (Piscataway,  NJ).  All  other
chemicals and solvents were of analytical grade and were
obtained from local companies.
Preparation of AGE antigens: AGE-BSA, MGO-BSA, and
CML  (carboxymethyl  lysine)-BSA  were  prepared  as
described previously [12,23,24]. Briefly, for AGE-BSA, BSA
(50  mg/ml)  was  incubated  with  1  M  glucose  in  0.2  M
phosphate buffer (pH 7.4) containing 0.05 % sodium azide at
37 °C for 90 days. For MGO-BSA, BSA (50 mg/ml) was
incubated  with  0.5  M  methylglyoxal  in  100  mM  sodium
phosphate buffer (pH 7.5) at 37 °C in dark for 3 days. Bovine
serum albumin (BSA, 50 mg/ml) was incubated with 0.045 M
glyoxylic acid and 0.15 M sodium cyanoborohydride in 0.2
M sodium phosphate buffer (pH7.8) for 24 h at 37 °C for the
preparation of CML-BSA. Low molecular weight reactants
and unbound sugars were removed by extensive dialysis.
Production of polyclonal anti-AGE antisera: Production of
polyclonal  antiserum  against  AGE-BSA,  MGO-BSA,  and
CML-BSA was described previously [23]. Briefly, 8–12 week
old  rabbits  were  immunized  with  respective  AGE-protein
antigens  (1  mg/ml)  in  Freund's  complete  adjuvant  and
subsequently three boosters were given at 3-week intervals in
Freund's incomplete adjuvant. The rabbits were bled after the
last booster, and the serum was collected. Antiserum was
partially purified by ammonium sulfate fractionation followed
by  DEAE-sepharose  anion  exchange  chromatography  to
obtain IgG rich fraction [12,23,24].
Preparation of ginger powder: Rhizomes of fresh wet ginger
(Zingiber officinalis) were collected from a local market in
one lot and freeze-dried using a lyophilizer (Virtis-Freeze
Mobile; SP Scientific, Stone Ridge, NY). The freeze-dried
material was powdered using a grinder-mixer and was mixed
with AIN-93M diet in required doses and fed to the rats.
Experimental design and dietary regimen: Two-month-old
male WNIN (Wistar-NIN) rats with an average bodyweight
of  220±17  g  (obtained  from  the  National  Centre  for
Laboratory Animal Sciences, Hyderabad, India) were used in
the study. All the animals were fed AIN-93 diet ad libitum.
The control (Group I; n=9) rats received 0.1 M citrate buffer,
pH 4.5 as a vehicle whereas the experimental rats received a
single intraperitoneal injection of STZ (35 mg/kg) in citrate
buffer.  After  72  h,  fasting  blood  glucose  levels  were
monitored. Animals having blood glucose levels <150 mg/dl
were  excluded  from  the  experiment  and  the  rest  were
distributed  into  three  groups  (Groups  II-IV).  Animals  in
Group II (n=12) received only AIN-93 diet whereas Group III
(n=9) and Group IV (n=9) animals received the AIN-93 diet
containing 0.5% and 3% freeze-dried powder of wet ginger,
respectively.
Animal care: Institutional and national guidelines for the care
and  use  of  animals  were  followed  and  all  experimental
procedures involving animals were approved by the IAEC
(institutional  animal  ethical  committee)  of  the  National
Institute  of  Nutrition.  Animals  were  housed  in  individual
cages in a temperature (22 °C) and humidity-controlled room
with a 12 h light/dark cycle. All the animals had free access
to water. Food intake (daily) and bodyweights (weekly) were
monitored. We adhered to the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research.
Slit  lamp  examination  and  cataract  grading:  Eyes  were
examined every week using a slit lamp biomicroscope (Kowa
Portable;  Kowa,  Ltd.,  Tokyo,  Japan)  on  dilated  pupils.
Initiation and progression of lens opacity was graded into five
categories as described previously [30]. Briefly, lens opacity
was graded as clear - clear lenses with no vacuoles; stage 1 -
vacuoles cover approximately one-half of the surface of the
anterior pole; stage 2 - some vacuoles have disappeared and
the cortex haziness; stage 3 - a hazy cortex remains and dense
nuclear opacity is present; stage 4 - a mature cataract.
Blood  and  lens  collection  and  processing:  Blood  was
collected once a week from the retro-orbital plexus for glucose
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1526and insulin estimation. At the end of 9 weeks, animals were
sacrificed by CO2 asphyxiation, and lenses were dissected by
the posterior approach [31]. Briefly, a small incision was made
on the posterior side of the eye with the scissors. The lenses
were collected by pressing with tweezers against the side of
the eye opposite of the incision and stored at −70 °C until
further analysis. A 10% homogenate was prepared from 3 to
4 pooled lenses in 50 mM phosphate buffer (pH 7.4). Some
of  the  biochemical  estimations  such  as  malondialdehyde
(MDA), sorbitol cannot be done with two lenses of each rat
as the rat lens weigh about 40 mg. Hence we pooled 3–4 lenses
for  making  homogenate  not  only  to  estimate  MDA  and
sorbitol but also for other biochemical estimations from the
same pool. All the biochemical parameters were analyzed in
the soluble fraction of the lens homogenate (15,000× g at 4 °C)
except for lens malondialdehyde (MDA) and sorbitol which
were determined in the total homogenate.
Biochemical estimations: Serum glucose was measured by the
glucose  oxidase-peroxidase  (GOD-POD)  method  using  a
commercially available kit (BioSystems S.A.Costa Brava 30,
Barcelona, Spain) and serum insulin was measured by a RIA
kit  (BRITE-DAE,  Mumbai,  India).  Lens  protein  carbonyl
content and the activities of aldose reductase (ALR2) and
sorbitol dehydrogenase (SDH) were determined according to
methods  described  previously  [23,30].  Total,  soluble,  and
insoluble protein was assayed by the Lowry method, with
BSA as a standard.
SDS–PAGE of lens proteins: The subunit profile and cross-
linking  of  lens  soluble  proteins  were  analyzed  on  12%
polyacrylamide gels in the presence of SDS under reducing
conditions [24,30].
Figure 1. Delay of diabetic cataract in
rats  by  ginger.  A:  Representative
photographs of lens from each group at
the  end  of  9  weeks.  B:  Quantitative
representation of cataract progression in
each group with time. Stage of cataract
in each group was averaged at a given
time and the average stage of cataract
along with standard error was plotted as
a function of time.
TABLE 1. EFFECT OF GINGER ON PROGRESSION OF DIABETIC CATARACT.
Cataract stage Group I Group II Group III Group IV
Clear 18 0 0 0
Stage <1 0 0 7 14
Stage 1–2 0 7 9 4
Stage 2–3 0 13 2 0
Stage 3–4 0 4 0 0
Number of lenses in each stage of cataract for different groups at the end of experiment.
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1527Immunodetection of AGE-antigens in the soluble fraction of
lens:  Lens  soluble  proteins  were  resolved  under  reducing
conditions on 12% SDS–PAGE, proteins were transferred
onto a nitrocellulose membrane (NC) and NC was blocked
with 5% skimmed milk powder. NC membrane was incubated
with partially purified antisera of AGE-BSA, MGO-BSA and
CML-BSA (1:100 dilution) later with HRP-conjugated goat
anti-rabbit  antibody  (1:500).  Subsequently,  detection  was
performed with diaminobenzidine in the presence of hydrogen
peroxide.
Immunoprecipitation of CML and MGO-AGE antigens in the
insoluble  fraction  of  lens:  Immunoprecipitation  (IP)  was
performed using 1 mg of reconstituted insoluble fraction of
lens in 500 μl of IP buffer (50 mM sodium phosphate buffer
pH 7.4). Partially purified polyclonal antisera of CML-BSA
or MGO-BSA was added at 1:100 dilution in IP buffer and
incubated at 4 °C overnight. To this, 50 μl of slurry of Protein-
A was added and incubated for 3 h at 4 °C. Immunocomplex
was collected by centrifugation at 10,000× g for 1 min at 4 °C
and complex was washed 3 times with 1 ml of IP buffer,
spinning at 10,000× g each time for 1 min. Finally, pellet was
washed with 50 mM Tris-HCl pH 7.9 and re-suspended in
sample buffer. Immunoblotting and detection was performed
as described above using anti-CML-BSA or anti-MGO-BSA
antiserum (1:100 dilution).
Figure  2.  Blood  glucose  and  insulin
levels. Effect of ginger on blood glucose
(A) and insulin levels (B) at the end of
study was shown. Data are mean±SD of
all  the  animals  in  a  group.  Different
superscripts above the bars denote that
data are significantly different among
the groups.
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1528Estimation  of  glycated  protein  by  boronate  affinity
chromatography:  The  percentage  of  glycated  protein  was
estimated  in  the  soluble  fraction  of  lens  as  described
previously [23,24]. Briefly, 5 mg of glycated lens protein was
passed through a phenyl boronate affinity column equilibrated
with 0.25 M ammonium acetate buffer (pH 8.5) containing
0.05 M MgCl2. The unbound fraction containing non-glycated
protein  was  washed  with  the  above  buffer,  while  bound
glycated  protein  was  eluted  using  0.1  M  2-amino-2-
hydroxymethyl-propane-1,3-diol-HCl  (pH  7.5)  containing
0.2 M sorbitol.
Statistical analysis: Trajectories were estimated using mixed
model analysis using SPSS software version 15.0 (SPSS Inc.,
Chicago, IL) to test the statistical significance of delay of
cataract progression due to ginger feeding. One-way ANOVA
was used for testing statistical significance between groups of
data and individual pair difference was tested by means of
Duncan’s multiple-range test. Heterogeneity of variance was
tested  by  the  nonparametric  Mann–Whitney  test  where  a
p<0.05 was considered as significant.
Figure  3.  Glycated  protein  in  soluble
fraction of lens. A: Amount of glycated
protein  in  soluble  protein  fraction  of
different groups was assayed by phenyl
boronate  affinity  chromatography  as
described  in  the  Methods  section.  B:
Percent of glycated protein in soluble
proteins  of  lens.  Data  are  mean±SD
(n=4). Different superscripts above the
bars denote that data are significantly
different among the groups.
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1529Figure 4. Sub unit profile and protein
cross-linking of soluble fraction of lens.
A: Soluble protein was loaded onto a
12% polyacrylamide gel under reducing
conditions. Molecular weight standards
in kDa are indicated alongside of the gel.
Lane  1-  Molecular  weight  markers;
Lane 2 - Group I; Lane 3 - Group II;
Lane 4 - Group III; Lane 5 - Group IV.
B: Densitometric quantification of cross
links.  Data  are  mean±SD  (n=4).
Intensity of protein bands above 31 kDa
was quantified considering the intensity
of  Group  I  as  100%.  Different
superscripts above the bars denote that
data are significantly different among
the groups.
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1530Food intake and bodyweights: As reported by us earlier [24,
30,32], there was an increase in the food intake in all the
diabetic animals compared with the control animals (data not
shown).  Studies  suggest  that  a  deficiency  of  hormones,
particularly  insulin  and  leptin,  causes  hyperphagia  in
streptozotocin (STZ) diabetic rats by altering the balance of
hypothalamic  neuropeptides  [33-35],  though  the  signaling
mechanisms  causing  diabetic  hyperphagia  are  still
incompletely  understood.  Irrespective  of  food  intake,  the
dynamics of amino nitrogen conversion is changed in a way
that favors protein catabolism of diabetic animals causing
weight  loss  [36].  Despite  the  increased  food  intake,  the
bodyweight of diabetic animals decreased significantly (mean
±SEM bodyweight at the end of experiment, 208±3.28 g;
p<0.001) when compared to control animals (290±2.96 g).
However feeding of ginger to diabetic rats (Group III and IV)
did not normalize the bodyweights to a significant extent
(217±2.55 g; p<0.001 and 225±5.50 g; p<0.001, respectively).
Cataract  progression:  While  the  onset  of  cataract  due  to
hyperglycemia was observed in diabetic animals after four
weeks of STZ injection and progressed to mature cataract by
eight weeks in untreated diabetic lenses, feeding of ginger
delayed both onset and progression of cataract in diabetic rats
in a dose dependent manner (Figure 1A). Since lenses were in
different stages of cataract in a given group at a given time,
the number lenses in each stage of cataract for different groups
at the end of experiment was shown (Table 1). Further, we
have averaged the stages at the given time at a given group,
to see the onset and progression of cataract in an empirical
manner  in  all  the  groups  and  presented  with  duration  of
diabetes (Figure 1B). Interestingly, there was a delay in the
onset of cataract in ginger fed groups as compared to untreated
diabetic group. At the end of the nine weeks, the severity of
cataract  was  significantly  lower  in  ginger-fed  groups,
particularly with 3% ginger, than in untreated diabetic rats.
All the lenses in control group appeared to be normal and free
of opacities during the experimental period. Based on the
trajectories (0, 1.169, 0.620, and 0.241, respectively for Group
I;  Group  II;  Group  III,  and  Group  IV)  which  are  highly
significant (p<0.001) at all the time intervals, the data suggests
that  progression  of  lens  abnormalities  and  maturation  of
cataract  due  to  STZ-induced  hyperglycemia  were
significantly  delayed  with  feeding  of  ginger  in  a  dose
dependent manner (Figure 1B). The doses of ginger used in
the study were based on a pilot study involving a small number
of rats (data not shown).
Blood glucose and insulin levels: We have assessed blood
glucose  and  insulin  levels  to  understand  whether  ginger
ameliorated cataract onset and progression by reducing STZ-
induced hyperglycemia. As expected blood glucose levels
were elevated and insulin levels were lowered significantly in
untreated diabetic animals compared to control rats (Figure
2). Though blood glucose levels were decreased to a marginal
(low dose) to moderate (high dose) level due to ginger feeding
to diabetic rats, insulin levels were unaffected by both levels
of ginger (Figure 2). Thus, a modest lowering of blood glucose
levels  in  diabetic  rats  by  ginger  feeding  is  supported  by
unaltered insulin levels. However, it should be noted that the
plasma  glucose  levels  in  ginger-fed  diabetic  rats  are
considerably higher than plasma glucose levels (150 mg/dl)
which are shown to induce cataract in WNIN rats after 4–5
weeks as seen in this study and earlier studies [24,30,32].
Therefore, delay of cataract progression in diabetic rats due
to  ginger  feeding  could  be  attributed  to  its  potential  to
modulate pathways that are linked to the development of
diabetic  complications  including  cataract  instead  of  mere
partial lowering of blood glucose level.
Molecular basis for the delay of cataract: To investigate the
possible mechanisms by which ginger delayed the onset and
progression of STZ-induced diabetic cataract, we have studied
various biochemical mechanisms related to cataractogenesis.
In view of in vitro antiglycating potential of ginger [23], we
have focused on non-enzymatic glycation mediated effects. In
addition  we  have  also  investigated  the  status  of  polyol
pathway and oxidative stress as there is a cross-talk between
these pathways [37,38].
Protein  glycation:  To  understand  that  ginger  feeding  to
diabetic rats could reduce the glycation, the percentage of
glycated protein in the lens was measured using boronate
affinity chromatography (Figure 3). While the percentage of
glycated protein in untreated diabetic rats was about 27%,
ginger feeding resulted in a reduction of glycated protein in a
dose  depended  manner  (Figure  3).  Further,  these  results
corroborate  with  our  previous  findings  of  in  vitro
TABLE 2. EFFECT OF GINGER ON PROTEIN CONTENT OF RAT LENS.
Parameter Group I Group II Group III Group IV
Total protein (mg/g lens) 480a±32.4 384b±22.7 434c±31.2 465a±35.8
Soluble protein (mg/g lens) 360a±27.3 198b±25.45 274c±40.5 310c±29.4
Soluble protein (%) 75.0 51.5 63.1 66.6
The total and soluble protein in the lens of different groups was estimated by the Lowry’s method and the percentage soluble
protein content was derived from the estimated values. The data are mean±SD (n=4). Different superscripts denote that data are
significantly different among the groups.
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RESULTSantiglycating potential of ginger. Despite their heterogeneity,
a  propensity  to  form  covalent  cross  links  is  the  common
consequence of AGE, which leads to the formation of high
molecular weight aggregates on proteins. Hence, we have
monitored  the  cross-links  of  lens  proteins  and  also  high
molecular weight (HMW) aggregates by SDS–PAGE. While
the  SDS–PAGE  pattern  of  soluble  protein  showed  an
increased proportion of cross linked and aggregated proteins
with the appearance of non-disulfide dimers of molecular
mass 45 kDa in the diabetic rat lens soluble proteins compared
with control, ginger fed groups showed a profile similar to
control group (Figure 4). Alteration in the protein profile due
to HMW aggregates lead to the insolubilization of protein that
have been considered to be the ultimate change that results in
lens opacification. Therefore, we have also analyzed total,
soluble, and insoluble protein content in all the groups. There
was a significant decrease in both total and soluble protein in
the untreated diabetic group compared with the control group.
Figure 5. Immunodetection of glucose
derived AGEs in the soluble portion of
lens protein. A: Representative western
blot  profile  of  soluble  lens  protein
probed with anti-AGE-BSA antibodies.
Lane  1:  Molecular  weight  markers,
Lane 2: Group I, Lane 3: Group II, Lane
4:  Group  III,  Lane  5:  Group  IV.  B:
Densitometry  analysis  of  AGE-BSA.
Intensity  of  AGE-BSA  signals  was
quantified considering the intensity of
lane 2 in upper panel as 100%. Data in
lower  panel  are  mean±SEM  of  three
independent experiments and different
superscripts  denote  that  data  are
significantly  different  among  the
groups.
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1532Generally during progression and subsequent maturation of
cataract, while there is a leakage of proteins from the lens due
to osmotic stress in addition to degradation of lens proteins
which is the main cause of decreased total protein content,
there is an insolubilization of available soluble protein due to
mechanisms mentioned above. Feeding the rats with ginger
improved the total and soluble protein levels, which is in
agreement with the delay of onset of cataract in those groups
(Table 2).
A wide variety of structurally diverse sugar-derived AGE
have  been  demonstrated  in  cataractous  lens  and  the
predominant  antigenic  AGE  are  argypyrimidine,
carboxyethyllysine,  carboxymethyllysine  [5-8,39-41].
Having shown the effective reduction of HMW aggregates in
the soluble fraction of lens upon feeding ginger, we evaluated
the immunoreactivity of some of these AGE using antibodies
raised against CML-BSA, MGO-BSA, and AGE-BSA in the
soluble as well as insoluble portion of lens protein. While
immunoreactivity of glucose derived AGE (AGE-BSA) was
found in the soluble portion (Figure 5), the presence of MGO-
BSA and CML could be detected in the insoluble protein
fraction (Figure 6 and Figure 7). Detection of increased AGE
in  the  insoluble  fraction  of  diabetic  lenses  indicates  that
formation of AGE on lens proteins led to aggregation and
insolubilization  of  proteins,  finally  resulting  in  cataract
formation. Feeding of rats with ginger reduced the formation
of  AGE  in  both  soluble  and  insoluble  protein  fraction
suggestive of its antiglycating action (Figure 5, Figure 6, and
Figure 7). Ginger was also effective against glyco-oxidative
damage to the eye lens as feeding of ginger could decrease
protein carbonyls which are increased in diabetic lens soluble
protein fraction (Figure 8).
Polyol  pathway:  Dicarbonyls  such  as  glyoxal  and  MGO,
produced  as  an  intermediate  of  the  Maillard  reaction,  are
substrates of aldose reductase (ALR2) [42], known to activate
the  polyol  pathway  under  hyperglycemic  conditions.  In
addition,  induction  of  ALR2  by  AGE  [43]  indicates  that
accelerated formation of AGE in vivo may elicit the activation
of the polyol pathway. Hence, having shown the reduction of
AGE, we evaluated the polyol pathway of lens upon ginger
feeding. Specific activity of polyol pathway enzymes ALR2
and SDH was significantly increased in untreated diabetic
animals compared to control rats. Feeding ginger to diabetic
rats resulted in normalization of ALR2 and SDH activities
(Table 3). However, we did not find significant inhibition of
ALR2 in vitro with aqueous extract of ginger in comparison
to other aqueous extracts [44]. Hence, probably the reduction
of carbonyl mediated stress (Figure 8) by ginger might be
responsible for restoring ALR2 activity after feeding ginger.
Further,  these  findings  are  in  concordance  with  previous
studies demonstrating a cross-talk between these pathways
[37,38,41,42].
Figure 6. Immunodetection of CML in
the  insoluble  portion  of  lens.  A:
Representative western blot profile of
insoluble lens protein probed with anti-
CML-BSA  antibodies.  Lane  1:
Molecular  weight  markers,  Lane  2:
Group  I,  Lane  3:  Group  II,  Lane  4:
Group  III,  Lane  5:  Group  IV.  B:
Densitometry  analysis  of  CML-BSA.
Intensity  of  CML-BSA  signals  was
quantified considering the intensity of
lane 2 in upper panel as 100%. Data in
lower  panel  are  mean±SEM  of  three
independent experiments and different
superscripts  denote  that  data  are
significantly  different  among  the
groups.
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Globally, the number of people with diabetes is projected to
rise from 171 million in 2000 to 330 million in 2030 [1,2,
45]. It has been estimated that India will have the largest
number of diabetic subjects in the world by the year 2025
[1,2,45]. Taking these projections into account, diabetes could
become a major threat to public health. Although, there have
been  major  advances  in  the  control  of  hyperglycemia
(diabetes)  through  dietary  changes,  hypoglycemic  agents,
insulin, and islet transplantation, the management of long-
term  complications  of  diabetes,  such  as  blindness  due  to
cataract and retinopathy, remain serious problems to be dealt
with. The impact of glycemic control in the prevention of
diabetic complications has been established by studies like the
UK Prospective Diabetes Study and the Diabetes Control and
Complications Trial. Nevertheless, perfect glycemic control
is not always possible. Further, persistence of progression of
hyperglycemia-induced complications during a subsequent
period of normal glucose homeostasis (called as memory of
glucose toxicity) [46], suggest that exclusive management of
glucose can no longer be viewed as sufficient for the control
of long-term complications. Hence, agents, which can prevent
diabetic  complications  irrespective  of  glycemic  control,
would  have  advantages  in  the  management  of  secondary
complications.
Several  mechanisms  have  been  proposed  to  explain
accelerated  cataract  formation  due  to  diabetes  [47,48].
Glycation induced structural damage to lens proteins resulting
in the formation of light scattering aggregates and ALR2
mediated  osmotic  stress  have  both  been  considered  as
predominant  factors.  Previously  we  have  identified  some
natural sources, including ginger, for their potential to inhibit
these  pathways  with  the  ultimate  goal  to  prevent  or  treat
diabetic  complications  [23,24,30,32,44].  In  this  study  we
demonstrated that the antiglycating effect of ginger could be
translated to delay the onset and progression of cataract in
experimental diabetic rats.
The  rhizome  of  ginger  contains  over  20  phenolic
compounds. The major active principles include zingiberene,
bisabolene, gingerols, and shogaols. These compounds have
been reported to display diverse biologic activities such as
antioxidant,  anti  inflammatory,  anticarcinogenic,
antidiabetic,  hypoglycemic,  hypolipidimic,  and  aldose
reductase  inhibitory  properties  [25-29,44,49].  Multiple
properties  of  these  active  components  could  also  be
responsible for the observed effect in the present study in
addition to its antiglycating potential that we have attributed
as a predominant mechanism for the delay of diabetic cataract.
Previous studies reported that active component of ginger
inhibited ALR2 and prevented the accumulation of galacitol
in the galactose induced cataract [50]. We also found that the
aqueous extract of ginger showed both antiglycating activity
and ALR2 inhibition [23,44]. Nevertheless, ginger seems to
modulate both glycation and polyol pathways because of a
cross-talk between these pathways. However, antiglycating
potential, not only in vitro but also in vivo, appears to be
predominant  over  ALR2  inhibition  [23,44].  Thus,  the
antiglycating nature of ginger could be the major mechanism
Figure  7.  Immunodetection  of  MGO-
AGE in the insoluble portion of lens.
A: Representative western blot profile
of  insoluble  lens  protein  probed  with
anti-MGO-BSA  antibodies.  Lane  1:
Molecular  weight  markers,  Lane  2:
Group  I,  Lane  3:  Group  II,  Lane  4:
Group  III,  Lane  5:  Group  IV.  B:
Densitometry  analysis  of  MGO-BSA.
Intensity  of  MGO-BSA  signals  was
quantified considering the intensity of
lane 2 in upper panel as 100%. Data in
lower  panel  are  mean±SEM  of  three
independent experiments and different
superscripts  denote  that  data  are
significantly  different  among  the
groups.
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studies with curcumin, cumin and tannoid-enriched fraction
of Emblica have shown that antioxidant, antiglycating and
ALR2  inhibition  were  partly  responsible  for  the  delay  of
diabetic cataract in rats [24,30,32]. Interestingly, unlike the
previous  studies,  besides  delaying  the  progression  and
maturation  of  cataract  a  significant  delay  in  the  onset  of
cataract by ginger was noticed in this study. This could be
attributed  to  its  ability  to  prevent  the  multiple  changes
associated with the accumulation of AGE, i.e., reduction in
the carbonyl stress, inhibition of osmotic stress by reducing
the activity of polyol pathway, and prevention of oxidative
stress [38].
In conclusion, results of the present study suggest that
agents  or  compounds  that  exert  multiple  actions  like
antiglycating, ALR2 inhibition, antioxidant, and antidiabetic/
hypoglycemic properties might provide a viable approach,
either food based or pharmacological, in the treatment of
diabetic complications.
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